Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Cervical Cancer

  Free Subscription


1 Arch Gynecol Obstet
1 Biologics
1 Biomed Res Int
1 BMC Cancer
1 BMC Infect Dis
1 BMC Pregnancy Childbirth
1 BMC Womens Health
1 Brachytherapy
1 Braz J Med Biol Res
1 Cancer Biother Radiopharm
1 Cancer Imaging
1 Cancer Res
1 Cell Cycle
1 Cell Mol Biol Lett
1 Clinicoecon Outcomes Res
1 Cureus
1 Cytokine
1 Eur Rev Med Pharmacol Sci
1 Front Genet
1 Front Oncol
1 Gynecol Oncol
1 Infect Dis Obstet Gynecol
1 Int J Clin Exp Pathol
1 Int J Equity Health
3 Int J Gynecol Cancer
3 Int J Radiat Oncol Biol Phys
1 J Cancer Epidemiol
1 J Cancer Surviv
1 J Cell Biochem
1 J Ethnopharmacol
3 J Gynecol Oncol
1 J Natl Med Assoc
1 J Obstet Gynaecol
1 J Obstet Gynaecol Res
1 Life Sci
1 Mater Sci Eng C Mater Biol Appl
1 Maturitas
1 Mol Clin Oncol
1 Nutr Clin Pract
1 Onco Targets Ther
2 Oncol Lett
1 PLoS One
2 Prev Med
1 Radiat Oncol
1 Saudi J Biol Sci
1 Syst Rev
1 Womens Health Issues
2 Zhonghua Zhong Liu Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Gynecol Obstet

  1. CAI S, Yu X, Gu Z, Yang Q, et al
    A 10-gene prognostic methylation signature for stage I-III cervical cancer.
    Arch Gynecol Obstet. 2020 Apr 9. pii: 10.1007/s00404-020-05524.
    PubMed         Abstract available


  2. Autophagy Regulates the Stemness of Cervical Cancer Stem Cells [Retraction].
    Biologics. 2020;14:35.
    PubMed         Abstract available

    Biomed Res Int

  3. WEI J, Wang Y, Shi K, Wang Y, et al
    Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Biomed Res Int. 2020;2020:8959210.
    PubMed         Abstract available

    BMC Cancer

  4. TUOHETI Z, Han L, Husaiyin S, Liu X, et al
    RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China.
    BMC Cancer. 2020;20:299.
    PubMed         Abstract available

    BMC Infect Dis

  5. ALLENDE G, Surriabre P, Ovando N, Calle P, et al
    Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
    BMC Infect Dis. 2020;20:259.
    PubMed         Abstract available

    BMC Pregnancy Childbirth

  6. GUO Y, Zhang D, Li Y, Wang Y, et al
    A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks.
    BMC Pregnancy Childbirth. 2020;20:202.
    PubMed         Abstract available

    BMC Womens Health

  7. WOLDETSADIK AB, Amhare AF, Bitew ST, Pei L, et al
    Socio-demographic characteristics and associated factors influencing cervical cancer screening among women attending in St. Paul's Teaching and Referral Hospital, Ethiopia.
    BMC Womens Health. 2020;20:70.
    PubMed         Abstract available


  8. DYER C
    Women whose cervical cancer was missed can have surrogacy abroad paid for by the NHS.
    BMJ. 2020;369:m1404.


  9. TANG X, Mu X, Zhao Z, Zhao H, et al
    Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis.
    Brachytherapy. 2020 Apr 4. pii: S1538-4721(20)30031.
    PubMed         Abstract available

    Braz J Med Biol Res

  10. SICHERO L, Picconi MA, Villa LL
    The contribution of Latin American research to HPV epidemiology and natural history knowledge.
    Braz J Med Biol Res. 2020;53:e9560.
    PubMed         Abstract available

    Cancer Biother Radiopharm

  11. CHI C, Li M, Hou W, Chen Y, et al
    Long Noncoding RNA SNHG7 Activates Wnt/beta-Catenin Signaling Pathway in Cervical Cancer Cells by Epigenetically Silencing DKK1.
    Cancer Biother Radiopharm. 2020 Apr 9. doi: 10.1089/cbr.2019.3004.
    PubMed         Abstract available

    Cancer Imaging

  12. PERUCHO JAU, Chiu KWH, Wong EMF, Tse KY, et al
    Diffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodes.
    Cancer Imaging. 2020;20:27.
    PubMed         Abstract available

    Cancer Res

  13. PARK Y, Pang K, Park J, Hong E, et al
    Destabilization of TRAF6 by DRAK1 suppresses tumor growth and metastasis in cervical cancer cells.
    Cancer Res. 2020 Apr 7. pii: 0008-5472.CAN-19-3428.
    PubMed         Abstract available

    Cell Cycle

  14. GUO Q, Zhang Q, Lu L, Xu Y, et al
    Long noncoding RNA RUSC1-AS1 promotes tumorigenesis in cervical cancer by acting as a competing endogenous RNA of microRNA-744 and consequently increasing Bcl-2 expression.
    Cell Cycle. 2020 Apr 8:1-14. doi: 10.1080/15384101.2020.1749468.
    PubMed         Abstract available

    Cell Mol Biol Lett

  15. XIA C, He Z, Cai Y
    Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
    Cell Mol Biol Lett. 2020;25:25.
    PubMed         Abstract available

    Clinicoecon Outcomes Res

  16. ARMSTRONG SF, Guest JF
    Cost-Effectiveness and Cost-Benefit of Cervical Cancer Screening with Liquid Based Cytology Compared with Conventional Cytology in Germany.
    Clinicoecon Outcomes Res. 2020;12:153-166.
    PubMed         Abstract available


  17. RIAZ L, Manazir S, Jawed F, Arshad Ali S, et al
    Knowledge, Perception, and Prevention Practices Related to Human Papillomavirus-based Cervical Cancer and Its Socioeconomic Correlates Among Women in Karachi, Pakistan.
    Cureus. 2020;12:e7183.
    PubMed         Abstract available


  18. TORRES-PINEDA DB, Mora-Garcia ML, Garcia-Rocha R, Hernandez-Montes J, et al
    Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells.
    Cytokine. 2020;130:155082.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  19. ZHANG L, Yao HR, Liu SK, Song LL, et al
    Long noncoding RNA ROR1AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/beta-catenin/EMT signaling cascade in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:2928-2937.
    PubMed         Abstract available

    Front Genet

  20. ZOU FW, Tang YF, Liu CY, Ma JA, et al
    Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis.
    Front Genet. 2020;11:200.
    PubMed         Abstract available

    Front Oncol

  21. MINNAAR CA, Kotzen JA, Ayeni OA, Vangu MD, et al
    Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients.
    Front Oncol. 2020;10:376.
    PubMed         Abstract available

    Gynecol Oncol

  22. GRIGSBY PW, Massad LS, Mutch DG, Powell MA, et al
    FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.
    Gynecol Oncol. 2020 Apr 2. pii: S0090-8258(20)30252.
    PubMed         Abstract available

    Infect Dis Obstet Gynecol

  23. AL-AMRO SQ, Gharaibeh MK, Oweis AI
    Factors Associated with Cervical Cancer Screening Uptake: Implications for the Health of Women in Jordan.
    Infect Dis Obstet Gynecol. 2020;2020:9690473.
    PubMed         Abstract available

    Int J Clin Exp Pathol

  24. ZHONG M, Liu Z, Wu K, Hong Z, et al
    Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-kappaB-Snail pathway.
    Int J Clin Exp Pathol. 2020;13:607-615.
    PubMed         Abstract available

    Int J Equity Health

  25. PORTNOY A, Clark S, Ozawa S, Jit M, et al
    The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study.
    Int J Equity Health. 2020;19:10.
    PubMed         Abstract available

    Int J Gynecol Cancer

  26. DOSTALEK L, Slama J, Fisherova D, Kocian R, et al
    Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2019-001113.
    PubMed         Abstract available

  27. CHEN X, Zhao N, Ye P, Chen J, et al
    Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size </=2 cm.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2019-000994.
    PubMed         Abstract available

  28. YOUN SH, Kim YJ, Seo SS, Kang S, et al
    Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea.
    Int J Gynecol Cancer. 2020 Apr 9. pii: ijgc-2020-001200.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  29. DALWADI SM, Bonnen MD, Ludwig MS
    In Regard to Albuquerque et al.
    Int J Radiat Oncol Biol Phys. 2020;106:888-889.

  30. CAPALDI DPI, Hristov DH, Kidd EA
    Parametric Response Mapping of Co-registered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radio-resistant Sub-volumes in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Apr 3. pii: S0360-3016(20)30951.
    PubMed         Abstract available

  31. ALBUQUERQUE K, Timmerman R
    In Reply to Dalwadi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:889.

    J BUON

  32. TOMASEVIC A, Plesinac Karapandzic V, Stojanovic Rundic S, Vuckovic S, et al
    3D MRI-based evaluation of the 2D brachytherapy planning in patients with advanced cervical cancer: An analysis of the delivered dose.
    J BUON. 2020;25:108-115.
    PubMed         Abstract available

  33. DJURIC O, Markovic Denic L, Popovac S, Todorovic J, et al
    Awareness and knowledge about HPV infection and HPV vaccination among women undergoing cytology and colposcopy in Serbian cervical cancer counseling center.
    J BUON. 2020;25:116-124.
    PubMed         Abstract available

  34. WU J, Wang N, Jin G, Xue L, et al
    Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway.
    J BUON. 2020;25:74-79.
    PubMed         Abstract available

  35. MENG X, Chu Y, Pan Y, Han L, et al
    Preoperative neoadjuvant chemotherapy combined with radical surgery in cervical cancer.
    J BUON. 2020;25:125-131.
    PubMed         Abstract available

  36. OU J, Meng F, Liu J, Li D, et al
    Ovatodiolide exerts anticancer effects on human cervical cancer cells via mitotic catastrophe, apoptosis and inhibition of NF-kB pathway.
    J BUON. 2020;25:87-92.
    PubMed         Abstract available

  37. YU L, Sun Y, Su J, Li X, et al
    Bismahanine exerts anticancer effects on human cervical cancer cells by inhibition of growth, migration and invasion via suppression of NF-kB signalling pathway.
    J BUON. 2020;25:93-98.
    PubMed         Abstract available

    J Cancer Epidemiol

  38. GETAHUN T, Kaba M, Derseh BT
    Intention to Screen for Cervical Cancer in Debre Berhan Town, Amhara Regional State, Ethiopia: Application of Theory of Planned Behavior.
    J Cancer Epidemiol. 2020;2020:3024578.
    PubMed         Abstract available

    J Cancer Surviv

  39. DAHL AA, Bentzen AG, Fossa SD, Hess SL, et al
    Long-term cervical cancer survivors on disability pension: a subgroup in need of attention from health care providers.
    J Cancer Surviv. 2020 Apr 11. pii: 10.1007/s11764-020-00877.
    PubMed         Abstract available

    J Cell Biochem

  40. XU YJ, Yu H, Liu GX
    Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    J Cell Biochem. 2020 Apr 10. doi: 10.1002/jcb.29650.
    PubMed         Abstract available

    J Ethnopharmacol

  41. WANG Y, Lu C, Huang H, Yao S, et al
    A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
    J Ethnopharmacol. 2020 Apr 7:112837. doi: 10.1016/j.jep.2020.112837.
    PubMed         Abstract available

    J Gynecol Oncol

  42. CIBULA D
    Management of patients with intermediate-risk early stage cervical cancer.
    J Gynecol Oncol. 2020 Feb 17. pii: 31.e54. doi: 10.3802/jgo.2020.

  43. SAITOH AOKI E, Yin R, Li K, Bhatla N, et al
    National screening programs for cervical cancer in Asian countries.
    J Gynecol Oncol. 2020 Feb 26. pii: 31.e55. doi: 10.3802/jgo.2020.
    PubMed         Abstract available

  44. SAKURAGI N, Murakami G, Konno Y, Kaneuchi M, et al
    Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer.
    J Gynecol Oncol. 2020 Jan 21. pii: 31.e49. doi: 10.3802/jgo.2020.
    PubMed         Abstract available

    J Natl Med Assoc

  45. BUSKWOFIE A, David-West G, Clare CA
    A Review of Cervical Cancer: Incidence and Disparities.
    J Natl Med Assoc. 2020 Apr 8. pii: S0027-9684(20)30043.
    PubMed         Abstract available

    J Obstet Gynaecol

  46. DAPPA E, Ramos R, Cunha TM, Ramos N, et al
    Intrauterine device migration into the bladder with stone formation after radiochemotherapy for cervical cancer: a case report.
    J Obstet Gynaecol. 2020 Apr 9:1-3. doi: 10.1080/01443615.2019.1693524.

    J Obstet Gynaecol Res

  47. ZENG F, Tuo Y, Liu D, He M, et al
    Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer.
    J Obstet Gynaecol Res. 2020 Apr 7. doi: 10.1111/jog.14237.
    PubMed         Abstract available

    Life Sci

  48. LUPI LA, Cucielo MS, Silveira HS, Gaiotte LB, et al
    The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
    Life Sci. 2020;247:117435.
    PubMed         Abstract available

    Mater Sci Eng C Mater Biol Appl

  49. XIA Y, Xiao M, Zhao M, Xu T, et al
    Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
    Mater Sci Eng C Mater Biol Appl. 2020;106:110100.
    PubMed         Abstract available


  50. ZAMORANO-LEON JJ, Lopez-de-Andres A, Alvarez-Gonzalez A, Astasio-Arbiza P, et al
    Reduction from 2011 to 2017 in adherence to breast cancer screening and non-improvement in the uptake of cervical cancer screening among women living in Spain.
    Maturitas. 2020;135:27-33.
    PubMed         Abstract available

    Mol Clin Oncol

  51. VINOTHKUMAR V, Arun K, Arunkumar G, Revathidevi S, et al
    Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
    Mol Clin Oncol. 2020;12:485-494.
    PubMed         Abstract available

    Nutr Clin Pract

  52. YOSHIKAWA N, Shirakawa A, Yoshida K, Tamauchi S, et al
    Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.
    Nutr Clin Pract. 2020 Apr 6. doi: 10.1002/ncp.10482.
    PubMed         Abstract available

    Onco Targets Ther

  53. ZHAO J, Yang T, Li L
    LncRNA FOXP4-AS1 Is Involved in Cervical Cancer Progression via Regulating miR-136-5p/CBX4 Axis.
    Onco Targets Ther. 2020;13:2347-2355.
    PubMed         Abstract available

    Oncol Lett

  54. YI Y, Fang Y, Wu K, Liu Y, et al
    Comprehensive gene and pathway analysis of cervical cancer progression.
    Oncol Lett. 2020;19:3316-3332.
    PubMed         Abstract available

  55. TANG Y, Zhao Y, Ran J, Wang Y, et al
    MicroRNA-21 promotes cell metastasis in cervical cancer through modulating epithelial-mesenchymal transition.
    Oncol Lett. 2020;19:3289-3295.
    PubMed         Abstract available

    PLoS One

  56. AYNALEM BY, Anteneh KT, Enyew MM
    Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study.
    PLoS One. 2020;15:e0231307.
    PubMed         Abstract available

    Prev Med

  57. BARTLEY SJ, Benard V, Tai E, Rockwell T, et al
    Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests?
    Prev Med. 2020 Apr 1:106078. doi: 10.1016/j.ypmed.2020.106078.
    PubMed         Abstract available

  58. HOLME F, Jeronimo J, Maldonado F, Camel C, et al
    Introduction of HPV testing for cervical cancer screening in Central America: the Scale-Up project.
    Prev Med. 2020 Apr 1:106076. doi: 10.1016/j.ypmed.2020.106076.
    PubMed         Abstract available

    Radiat Oncol

  59. MENDEZ LC, Ravi A, Martell K, Raziee H, et al
    Comparison of CTVHR and organs at risk contours between TRUS and MR images in IB cervical cancers: a proof of concept study.
    Radiat Oncol. 2020;15:73.
    PubMed         Abstract available

    Saudi J Biol Sci

  60. ZHANG L, Chinnathambi A, Alharbi SA, Veeraraghavan VP, et al
    Punicalagin promotes the apoptosis in human cervical cancer (ME-180) cells through mitochondrial pathway and by inhibiting the NF-kB signaling pathway.
    Saudi J Biol Sci. 2020;27:1100-1106.
    PubMed         Abstract available

    Syst Rev

  61. MAPANGA W, Singh E, Feresu SA, Girdler-Brown B, et al
    Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review.
    Syst Rev. 2020;9:79.
    PubMed         Abstract available

    Womens Health Issues

  62. SOLAZZO AL, Agenor M, Austin SB, Chavarro JE, et al
    Sexual Orientation Differences in Cervical Cancer Prevention among a Cohort of U.S. Women.
    Womens Health Issues. 2020 Apr 2. pii: S1049-3867(20)30014.
    PubMed         Abstract available

    Zhonghua Zhong Liu Za Zhi

  63. ZHANG SK, Luo XP, Li ZF, Su Z, et al
    [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhonghua Zhong Liu Za Zhi. 2020;42:252-256.
    PubMed         Abstract available

  64. WANG GC, Gao CQ, Liu YJ, Han GS, et al
    [Retrospective analysis of curative effect of total pelvic organ resection and anal preservation in 20 patients with recurrence of cervical cancer after radical radiotherapy].
    Zhonghua Zhong Liu Za Zhi. 2020;42:242-246.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.